メインコンテンツへスキップ
見出し画像

Synopsys Uncovered: The AI Powerhouse Shaping the Future of Chip Design and Stock Growth

    1) What is Synopsys?

    Synopsys (NASDAQ: SNPS) is one of the world’s largest providers of chip design software (EDA: Electronic Design Automation) and semiconductor intellectual property (IP). Its business is divided into two main reporting segments: Design Automation (software for designing chips) and Design IP (ready-made building blocks licensed to chipmakers).

    In July 2025, Synopsys completed the acquisition of Ansys, a leader in engineering simulation software. This move combines chip design (Synopsys) with physics-based system simulation (Ansys), allowing Synopsys to cover end-to-end design workflows. The company stated this expands its total addressable market (TAM) to $31 billion.


    2) Key Facts: Stock Price, Earnings Schedule, Last Results

    • Stock Price: As of early September 2025, Synopsys trades around $598 per share.

    • Next Earnings: Synopsys will report Q3 FY2025 results on September 9, 2025 (after U.S. market close). The earnings call is scheduled at 5:00 PM ET / 2:00 PM PT.

    • Last Quarter (Q2 FY2025): Revenue of $1.604 billion and Non-GAAP EPS of $3.67.

    画像

    3) Quick Refresher on Terms

    • EPS = Earnings Per Share. Profit per share of stock.

    • P/E Ratio (PER) = Price-to-Earnings ratio. How many times earnings investors are paying for the stock.

    • TTM = Trailing Twelve Months (sum of the last 4 quarters).


    4) Current Valuation: Where Does SNPS Stand?

    • EPS (TTM): About $14.06 (as of April 2025).

    • P/E (TTM): Roughly 42–43×.

    • 10-Year History: Average ~59×, with extremes from ~24× (2019) to nearly 299× (2018).

    Peer comparison: Cadence Design Systems (CDNS), Synopsys’s closest competitor, currently trades at a much higher P/E ratio in the 90s.

    👉 Takeaway: Synopsys’s current valuation (~42×) is below its historical average and significantly lower than Cadence. That suggests Synopsys may look more conservative on a relative basis.


    5) EPS × PER Range Analysis

    Using EPS TTM = $14.06, we can create “valuation zones” based on reasonable P/E multiples:

    • Conservative Range: 40–55× → $562–$773

    • Core Range (based on historical median): 50–70× → $703–$984

    • Aggressive Growth Range: 60–80× → $844–$1,125

    This gives investors a framework to judge whether the current price (~$598) sits in the lower, middle, or upper valuation zone.


    6) Upcoming Earnings: Three Scenarios

    Company Guidance (Q3 FY2025): Non-GAAP EPS $3.82–$3.87, revenue $1.755–$1.785B. Consensus is around $3.84 EPS.

    Scenario Outlook:

    • Positive Surprise: EPS beats $3.87 and strong guidance → market could award higher multiples (60–80×).

    • In-line: EPS within $3.82–$3.87 → valuation stays around 50–70×.

    • Disappointment: EPS below $3.80 or weak guidance → compression to 40–50×.


    7) Recession Stress Test (Hypothetical)

    Assuming both EPS and P/E contract in a downturn:

    • Mild recession: EPS –15% → ~$12; P/E 45× → ~$540

    • Moderate: EPS –30% → ~$10; P/E 40× → ~$400

    • Severe: EPS –45% → ~$8; P/E 35× → ~$280

    This exercise helps frame downside risk tolerance.


    8) Long-Term Growth Drivers

    • AI & Advanced Chip Design: AI chips, 3D-IC, and increasingly complex systems create sustained demand for EDA. Synopsys has received high ratings (e.g., IBD Composite 96).

    • Ansys Synergy: Combining chip and system simulation enables faster design cycles and more optimized products, expanding its customer base beyond semiconductors.

    • Consensus Price Targets: Analysts’ 12-month target averages around $655, with upside of about 9% from current levels.

    Risks: macroeconomic headwinds, U.S.–China tech restrictions, and integration challenges after the Ansys merger. Note: regulatory approvals have already been granted.


    9) Thinking About Entry Timing (General Considerations)

    Not financial advice—just frameworks investors often use:

    1. Post-earnings volatility: Splitting purchases across several days after earnings can smooth entry points.

    2. Technical support: IBD notes Synopsys often finds support near its 50-day moving average.

    3. Dual-range planning: Use both an “upside range” (EPS × PER valuation) and a “downside safety range” (recession stress test) to frame expectations.

    4. Peer watch: If Cadence trades at a 90× P/E while Synopsys sits at ~42×, relative valuation may provide perspective.


    10) One-Page Takeaway

    • Upcoming event: Q3 FY2025 earnings on Sept 9, 2025.

    • Last quarter: Revenue $1.604B, EPS $3.67.

    • Valuation: P/E ~42× vs. 10-year avg 59× and Cadence at ~90×.

    • Growth story: AI + Ansys integration create structural demand tailwinds.

    • Strategy lens: Treat earnings dips or technical pullbacks as possible entry zones, while keeping both upside targets and downside scenarios in mind.


    References

    • Synopsys Investor Relations (earnings release & schedule)

    • Ansys acquisition press releases

    • EPS & P/E history (Fullratio)

    • Peer comparison: Cadence P/E (Macrotrends, Yahoo, GuruFocus)

    • Analyst forecasts (TipRanks)

    • IBD coverage & composite rating


    ⚠️ Disclaimer: This article is for information only and not investment advice. Numbers and ranges include assumptions. Always evaluate your own risk tolerance before making decisions.

     
     
    産廃処理業の設備課課長代理2年目突入|元機械系エンジニア|保全・経営・資格勉強|子育てとAIと科学が好きな30代パパです。このnoteでは一般サラリーマンの私が日々AIと共に考えたことをAIでアウトプットしていきます。拙い内容ですが少しでも皆さんのお役に立てますと幸いです。

    あなたへのおすすめ